Gagneur Arnaud, Roy David, Pelletier Catherine, Trottier Marie-Eve, Lemaire-Paquette Samuel, Rousseau Marina, Dubé Ève, Verger Pierre
Département de Pédiatrie, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Département de Pédiaterie, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.
Hum Vaccin Immunother. 2025 Dec;21(1):2499345. doi: 10.1080/21645515.2025.2499345. Epub 2025 May 4.
Vaccine hesitancy poses a significant challenge to worldwide public health and has been exacerbated by the COVID-19 pandemic, leading to heightened polarization and the spread of misinformation. Addressing vaccine hesitancy requires multifaceted strategies in which healthcare professionals (HCPs) play a critical role. Nonetheless, HCPs may also be hesitant toward vaccination. The 31-item original Pro-VC-Be tool, designed to measure the psychosocial determinants of vaccine attitudes in HCPs, was first validated in France, French-speaking Belgian regions, and Quebec (Canada). The validity of a short-form version was evaluated and found to be comparable to that of the long-form. Given differing vaccination recommendations and the changing pandemic context, assessing the tool's stability among diverse Canadian HCPs is crucial. Relying on the original short version of the Pro-VC-Be tool, a cross-sectional online survey was conducted among various Canadian HCPs ( = 544) to explore the psychosocial determinants that impact vaccination-related behaviors (frequency of general vaccination activity, vaccine recommendations activity, and willingness to recommend vaccines). The findings underscore three crucial dimensions - vaccine confidence, proactive efficacy, and trust in authorities - as robust predictors of positive professional practice and attitudes, and thus globally support the results obtained in previous studies using the Pro-VC-Be tool. HCPs with higher vaccine confidence, high proactive efficacy, and higher trust in authorities were 80% and 180% more likely to recommend vaccines to their patients and 80% more likely to have received a COVID-19 vaccine than other HCPs, respectively. By identifying the root causes of vaccine hesitancy among HCPs, adapted strategies can be developed.
疫苗犹豫对全球公共卫生构成了重大挑战,并且因新冠疫情而加剧,导致两极分化加剧和错误信息传播。应对疫苗犹豫需要多方面的策略,其中医疗保健专业人员(HCPs)发挥着关键作用。尽管如此,HCPs自身也可能对疫苗接种持犹豫态度。最初的31项Pro-VC-Be工具旨在衡量HCPs疫苗态度的心理社会决定因素,该工具首先在法国、比利时法语区和魁北克(加拿大)得到验证。对其简版的有效性进行了评估,发现与完整版相当。鉴于不同的疫苗接种建议以及不断变化的疫情背景,评估该工具在加拿大不同HCPs中的稳定性至关重要。依托Pro-VC-Be工具的原始简版,对加拿大各类HCPs(n = 544)开展了一项横断面在线调查,以探究影响疫苗接种相关行为(一般疫苗接种活动频率、疫苗推荐活动以及推荐疫苗的意愿)的心理社会决定因素。研究结果强调了三个关键维度——疫苗信心、积极效能和对当局的信任——作为积极专业实践和态度的有力预测指标,从而总体上支持了此前使用Pro-VC-Be工具所获得的研究结果。与其他HCPs相比,疫苗信心更高、积极效能高且对当局信任度更高的HCPs向患者推荐疫苗的可能性分别高出80%和180%,接种新冠疫苗的可能性高出80%。通过确定HCPs中疫苗犹豫的根本原因,可以制定适应性策略。